Landmark TrialRCTRandomized Controlled Trial
Goal-Directed Resuscitation for Patients with Early Septic Shock
New England Journal of Medicine2014IF: 25.4
The ARISE Investigators and the ANZICS Clinical Trials Group
Abstract
In critically ill patients presenting to the emergency department with early septic shock, EGDT did not reduce all-cause mortality at 90 days. (Funded by the National Health and Medical Research Council of Australia and the Alfred Foundation; ARISE ClinicalTrials.gov number, NCT00975793.).